SCHEMBL5159353

SCHEMBL5159353

CSCC[C@H](NC(=O)CCC(C)C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FNTA P49354 5/20 0.53
FNTB P49356 5/20 0.53
PGGT1B P53609 1/20 0.52
FOLH1 Q04609 1/20 0.51
ALDH1A1 P00352 3/20 0.49
GAA P10253 1/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 2/20 0.47
NOD1 Q9Y239 1/20 0.46
USP2 O75604 1/20 0.46
TP53 P04637 1/20 0.46
ALOX15 P16050 1/20 0.46
NPSR1 Q6W5P4 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11423937 0.88 FNTA (0.59) FNTAFNTBPGGT1BFOLH1ALDH1A1
SCHEMBL22100185 0.85 NOD1 (0.43) FNTAFNTBPGGT1BFOLH1ALDH1A1
SCHEMBL302151 0.85 FNTA (0.58) FNTAFNTBPGGT1BALDH1A1LMNA
SCHEMBL11413338 0.85 FOLH1 (0.53) FNTAFNTBPGGT1BFOLH1ALDH1A1
SCHEMBL753572 0.85 FNTA (0.60) FNTAFNTBPGGT1BFOLH1ALDH1A1
SCHEMBL9554921 0.85 FOLH1 (0.53) FNTAFNTBPGGT1BFOLH1ALDH1A1
SCHEMBL14554164 0.85 FNTA (0.60) FNTAFNTBPGGT1BFOLH1ALDH1A1
SCHEMBL302152 0.85 FNTA (0.58) FNTAFNTBPGGT1BALDH1A1LMNA
SCHEMBL29941368 0.85 GNPAT (0.57) FNTAFNTBPGGT1BFOLH1ALDH1A1
SCHEMBL1956539 0.84 FNTA (0.60) FNTAFNTBPGGT1BNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1104438-B1 NOVEL ANTI-DIABETIC PEPTIDES AMYLIN PHARMACEUTICALS INC (US) 2007-02-21 EP disclosed
EP-1104438-A2 NOVEL ANTI-DIABETIC PEPTIDES AMYLIN PHARMACEUTICALS, INC. (US) 2001-06-06 EP disclosed
US-6087334-A POLYPEPTIDES AS AN AMYLIN AGONISTS, CALCITONIN AGONISTS, ALSO AS A DRUG FOR REGULATING GASTROINTESTINAL MOTILITY, TREATING DISTURBANCES IN FUEL METABOLISM IN MAMMALS AMYLIN PHARMACEUTICALS, INC. (US) 2000-07-11 US disclosed
WO-2000011029-A2 NOVEL ANTI-DIABETIC PEPTIDES AMYLIN PHARMACEUTICALS, INC. (US) 2000-03-02 WO disclosed